Urea cycle disorders are congenital diseases that are caused by a dysfunctional urea cycle. The genetics and biochemistry of these disorders have been extensively studied. They are the result of a ...
DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics plc (Nasdaq: HZNP) in partnership with Invitae Corporation (NYSE: NVTA) today announced a new urea cycle disorder (UCD) genetic testing program designed ...
According to a recent Future Market Insights analysis, the global hyperammonemia treatment market is anticipated to reach a valuation of US$ 1,318.05 Million in 2023 and US$ 2,100 Million by 2033, ...
Hosted virtual Analyst Day showcasing lead program KRRO-121’s potential to be a first-in-class transformational treatment for hyperammonemia in patients with urea cycle disorders (UCDs) and hepatic ...
SOUTH SAN FRANCISCO, Calif., March 30, 2009 /PRNewswire via COMTEX/ ----Hyperion Therapeutics, Inc. today announced top-line results from their phase II study of HPN-100 for the treatment of urea ...
The simple notion of copying the body's own natural "waste disposal" chemistry to mop up potentially toxic nitrogen has saved an estimated 80 percent of patients with urea cycle disorders -- most of ...
The specific symptoms of disorders related to the urea cycle vary among the different types of these disorders. Typically, with complete deficiency of urea cycle enzymes, symptoms present within the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results